FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387300192> ?p ?o ?g. }

• W4387300192 endingPage "224154" @default.
• W4387300192 startingPage "ard" @default.
• W4387300192 abstract "Objectives To determine the risk of adverse events associated with colchicine or non-steroidal anti-inflammatory drug (NSAID) prophylaxis when initiating allopurinol for gout. Methods We conducted two matched retrospective cohort studies in linked UK Clinical Practice Research Datalink and Hospital Episode Statistics datasets. Adults initiating allopurinol for gout with (1) colchicine or (2) NSAID prophylaxis were compared with those initiating without prophylaxis, individually matched by age, sex and propensity to receive the relevant prophylaxis. Weighted Cox proportional hazards models investigated associations between colchicine/NSAID and specified adverse events. Results 13 945 individuals prescribed colchicine were matched to 13 945 with no prophylaxis and 25 980 prescribed NSAID to 25 980 with no prophylaxis. Adverse event incidence rates were <200/10 000 patient-years except diarrhoea (784.4; 95% CI 694.0 to 886.5) and nausea (208.1; 95% CI 165.4 to 261.7) for colchicine and angina for NSAID (466.6; 95% CI 417.2 to 521.8). Diarrhoea (HR 2.22; 95% CI 1.83 to 2.69), myocardial infarction (MI) (1.55; 95% CI 1.10, 2.17), neuropathy (4.75; 95% CI 1.20 to 18.76), myalgia (2.64; 95% CI 1.45 to 4.81), bone marrow suppression (3.29; 95% CI 1.43 to 7.58) and any adverse event (1.91, 95% CI 1.65 to 2.20) were more common with colchicine than no prophylaxis, but not nausea/vomiting (1.34; 95% CI 0.97 to 1.85). Angina (1.60; 95% CI 1.37 to 1.86), acute kidney injury (1.56; 95% CI 1.20 to 2.03), MI (1.89; 95% CI 1.44 to 2.48), peptic ulcer disease (1.67; 95% CI 1.14 to 2.44) and any adverse event (1.63; 95% CI 1.44 to 1.85) were more common with NSAID than without. Conclusions Adverse events were more common when allopurinol was initiated with prophylaxis, particularly diarrhoea with colchicine. Other events were uncommon, providing reassurance for patients and clinicians to enable shared decision-making." @default.
• W4387300192 created "2023-10-04" @default.
• W4387300192 creator A5013162170 @default.
• W4387300192 creator A5016692870 @default.
• W4387300192 creator A5027298393 @default.
• W4387300192 creator A5037905583 @default.
• W4387300192 creator A5043632337 @default.
• W4387300192 creator A5053249307 @default.
• W4387300192 creator A5058717987 @default.
• W4387300192 creator A5067652449 @default.
• W4387300192 creator A5077430930 @default.
• W4387300192 date "2023-10-03" @default.
• W4387300192 modified "2023-10-05" @default.
• W4387300192 title "Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink" @default.
• W4387300192 cites W1575211640 @default.
• W4387300192 cites W1599185368 @default.
• W4387300192 cites W1985359478 @default.
• W4387300192 cites W1994439773 @default.
• W4387300192 cites W2029616970 @default.
• W4387300192 cites W2036193982 @default.
• W4387300192 cites W2036201394 @default.
• W4387300192 cites W2110950087 @default.
• W4387300192 cites W2113978145 @default.
• W4387300192 cites W2119852447 @default.
• W4387300192 cites W2133654459 @default.
• W4387300192 cites W2163589808 @default.
• W4387300192 cites W2220529123 @default.
• W4387300192 cites W2335302945 @default.
• W4387300192 cites W2592762700 @default.
• W4387300192 cites W2613818341 @default.
• W4387300192 cites W2735301415 @default.
• W4387300192 cites W2801094241 @default.
• W4387300192 cites W2896236948 @default.
• W4387300192 cites W2986700515 @default.
• W4387300192 cites W3006620389 @default.
• W4387300192 cites W3028476381 @default.
• W4387300192 cites W3036502129 @default.
• W4387300192 cites W3081761942 @default.
• W4387300192 cites W3082165044 @default.
• W4387300192 cites W3092669347 @default.
• W4387300192 cites W3149026346 @default.
• W4387300192 cites W4229537562 @default.
• W4387300192 cites W4246591040 @default.
• W4387300192 cites W4249268074 @default.
• W4387300192 cites W4281563502 @default.
• W4387300192 cites W4283721442 @default.
• W4387300192 cites W4293576329 @default.
• W4387300192 cites W4312095361 @default.
• W4387300192 cites W4365793099 @default.
• W4387300192 doi "https://doi.org/10.1136/ard-2023-224154" @default.
• W4387300192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37788904" @default.
• W4387300192 hasPublicationYear "2023" @default.
• W4387300192 type Work @default.
• W4387300192 citedByCount "0" @default.
• W4387300192 crossrefType "journal-article" @default.
• W4387300192 hasAuthorship W4387300192A5013162170 @default.
• W4387300192 hasAuthorship W4387300192A5016692870 @default.
• W4387300192 hasAuthorship W4387300192A5027298393 @default.
• W4387300192 hasAuthorship W4387300192A5037905583 @default.
• W4387300192 hasAuthorship W4387300192A5043632337 @default.
• W4387300192 hasAuthorship W4387300192A5053249307 @default.
• W4387300192 hasAuthorship W4387300192A5058717987 @default.
• W4387300192 hasAuthorship W4387300192A5067652449 @default.
• W4387300192 hasAuthorship W4387300192A5077430930 @default.
• W4387300192 hasBestOaLocation W43873001921 @default.
• W4387300192 hasConcept C126322002 @default.
• W4387300192 hasConcept C141071460 @default.
• W4387300192 hasConcept C17923572 @default.
• W4387300192 hasConcept C197934379 @default.
• W4387300192 hasConcept C201903717 @default.
• W4387300192 hasConcept C2778616394 @default.
• W4387300192 hasConcept C2780261098 @default.
• W4387300192 hasConcept C2780402116 @default.
• W4387300192 hasConcept C2780580376 @default.
• W4387300192 hasConcept C71924100 @default.
• W4387300192 hasConcept C72563966 @default.
• W4387300192 hasConceptScore W4387300192C126322002 @default.
• W4387300192 hasConceptScore W4387300192C141071460 @default.
• W4387300192 hasConceptScore W4387300192C17923572 @default.
• W4387300192 hasConceptScore W4387300192C197934379 @default.
• W4387300192 hasConceptScore W4387300192C201903717 @default.
• W4387300192 hasConceptScore W4387300192C2778616394 @default.
• W4387300192 hasConceptScore W4387300192C2780261098 @default.
• W4387300192 hasConceptScore W4387300192C2780402116 @default.
• W4387300192 hasConceptScore W4387300192C2780580376 @default.
• W4387300192 hasConceptScore W4387300192C71924100 @default.
• W4387300192 hasConceptScore W4387300192C72563966 @default.
• W4387300192 hasFunder F4320319990 @default.
• W4387300192 hasLocation W43873001921 @default.
• W4387300192 hasLocation W43873001922 @default.
• W4387300192 hasOpenAccess W4387300192 @default.
• W4387300192 hasPrimaryLocation W43873001921 @default.
• W4387300192 hasRelatedWork W1878162582 @default.
• W4387300192 hasRelatedWork W1923847632 @default.
• W4387300192 hasRelatedWork W1973808919 @default.
• W4387300192 hasRelatedWork W2171311050 @default.
• W4387300192 hasRelatedWork W2185280552 @default.
• W4387300192 hasRelatedWork W2791358547 @default.

• next